Apollo
logo
  1. Home
  2. salt
  3. Docaravimab+miromavimab

Docaravimab+miromavimab

About Docaravimab+miromavimab

Docaravimab+miromavimab is a specialised medicine injected to prevent rabies after a person has been scratched or bitten by a potentially rabid animal. This emergency treatment is injected as soon as possible after exposure. It is designed to work immediately to neutralise the virus at the wound site before it can reach the nervous system.

This preventative treatment is injected as a single, one-time dose. Thoroughly washing the wound with soap and water immediately after the bite is a critical step that must be done alongside receiving this injection. No long-term dietary changes are needed, but resting and keeping the injection area clean will help your body heal.

While the injection is generally well-tolerated, some people may experience mild soreness, swelling, or redness at the injection site. Serious side effects are rare, but you must contact a doctor immediately if you notice signs of a severe allergic reaction, such as trouble breathing, hives, or swelling of the face and throat.

Do not take this if you have had a severe allergic reaction to similar antibody treatments in the past. Talk to your doctor before receiving this injection if you have a bleeding disorder, as muscle injections can cause bruising or bleeding.

Tell your healthcare provider about all medicines you take, as immune-suppressing drugs can affect how your body builds protection. If you are pregnant, breastfeeding, or caring for an elderly patient, discuss this with your doctor, though rabies prevention remains an absolute medical priority.

Uses of Docaravimab+miromavimab

Docaravimab+miromavimab is used in post-exposure rabies prevention. The detailed uses of Docaravimab+miromavimab are as follows: • Prevention of post-exposure rabies: Docaravimab+miromavimab is used for post-exposure rabies prevention. • Prevents clinical symptoms: Docaravimab+miromavimab helps prevent clinical symptoms and fatal progression of rabies.

Medicinal Benefits

Using Docaravimab+miromavimab as prescribed provides immediate protection against rabies following a suspected exposure. Here are the key benefits you can expect:

  • Provides immediate protection: Docaravimab+miromavimab contains ready-made antibodies that help neutralise the rabies virus at the exposure site, offering immediate protection while your body develops its own immunity from the rabies vaccine.
  • Helps prevent the spread of the virus: By acting directly at the bite or scratch site, Docaravimab+miromavimab reduces the risk of the rabies virus entering the nerves and spreading to the brain and spinal cord.
  • Complements rabies vaccination: Docaravimab+miromavimab works alongside the rabies vaccine by providing passive immunity during the first few days, ensuring continuous protection until the vaccine produces a long-lasting immune response.

Directions for Use

  • Follow your doctor’s instructions on the dosage and timing of this medication.
  • Docaravimab+miromavimab is administered by the doctor or healthcare professional.
  • Do not self-administer.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Docaravimab+miromavimab

Common Side Effects (Usually mild)

  • Pain, redness, or swelling at the injection site
  • Mild fever or feeling generally unwell
  • Headache
  • Muscle pain or body aches


Serious Side Effects (Consult your doctor right away)

  • Signs of a severe allergic reaction, such as difficulty breathing, swelling of the face, lips, tongue, or throat, and severe hives
  • High fever that does not go down
  • Severe dizziness or feeling faint

 

Drug Warnings

  • Inspect before administration: Ensure the injection solution is clear to slightly cloudy and free of visible particles before it is administered.
  • Separate administration: Make sure Docaravimab+miromavimab and the rabies vaccine are administered using separate syringes and at different injection sites.
  • Seek prompt treatment: Get treated as soon as possible after an animal bite, scratch, or saliva exposure, as rabies post-exposure treatment is most effective when started immediately.
  • Report all exposure sites: Tell your doctor about every bite, scratch, or area of broken skin so the medicine can be administered to all potential exposure sites.
  • Complete the vaccine schedule: Do not miss any follow-up appointments for your rabies vaccine series, as Docaravimab+miromavimab provides temporary protection while the vaccine helps develop long-term immunity.

Drug Interactions

  • Rabies vaccine: Must not be mixed in the same syringe or injected into the same muscle site as Docaravimab+miromavimab, as the antibodies can neutralise the vaccine before it can trigger your immune system.
  • Immunosuppressive medicines: Drugs like chemotherapy, radiation, or high-dose corticosteroids may weaken your body's immune response to the rabies vaccine given alongside Docaravimab+miromavimab.

Drug-Drug Interactions Checker List:

Safety Advice

  • Safety Warning

    Alcohol

    consult your doctor

    There is no evidence that alcohol affects the medication's effectiveness. Please consult your doctor about the safety of consuming alcohol with Docaravimab+miromavimab.

  • Safety Warning

    Pregnancy

    consult your doctor

    Before receiving Docaravimab+miromavimab, consult your doctor, as limited information is available for the use of Docaravimab+miromavimab in pregnant women.

  • Safety Warning

    Breast Feeding

    consult your doctor

    Please consult your doctor if you are a breastfeeding mother, as limited information is available for the use of Docaravimab+miromavimab in breastfeeding mothers.

  • Safety Warning

    Driving

    consult your doctor

    It is unclear whether Docaravimab+miromavimab affects your ability to drive. Refrain from driving if you suspect any difficulty.

  • Safety Warning

    Liver

    consult your doctor

    There is limited information available on the use of Docaravimab+miromavimab in individuals with liver problems. You are recommended to consult a doctor for further guidance.

  • Safety Warning

    Kidney

    consult your doctor

    There is limited information available on the use of Docaravimab+miromavimab in individuals with kidney problems. You are recommended to consult a doctor for further guidance.

  • Safety Warning

    Children

    consult your doctor

    Please consult your doctor before administering Docaravimab+miromavimab to your child, as there is limited information available.

Habit Forming

No

Diet & Lifestyle Advise

  • Wash the wound immediately: Before receiving any injections, wash the bite or scratch thoroughly with plenty of soap and running water for at least 15 minutes to physically flush out the virus.
  • Stay hydrated and rest: Your body needs energy to build a strong immune response alongside the rabies vaccine. Drink plenty of water and get extra sleep in the days following your injections.
  • Avoid alcohol: Refrain from drinking alcohol during your rabies treatment schedule, as alcohol can temporarily suppress your immune system and make it harder to monitor for vaccine side effects.
  • Protect the injection site: Keep the injection area clean and dry. Avoid rubbing or massaging the injection sites to prevent irritation and allow the tissue to heal.

Special Advise

Patients Concern

Disease/Condition Glossary

Rabies: It is a viral disease caused by the rabies virus. It is primarily transmitted through bites or scratches from infected animals, especially dogs. It has two forms: furious rabies through hyperactivity and hallucinations, and paralytic rabies. Symptoms include fever, pain at the bite site, hydrophobia (fear of water), hallucinations, and muscle paralysis. Rabies is fatal once clinical symptoms appear, but it can be prevented with prompt post-exposure prophylaxis (PEP), which includes wound washing, rabies vaccination, and if needed, rabies immunoglobulin (RIG).

FAQs

Docaravimab+miromavimab is used in post-exposure rabies prophylaxis (prevention).

Docaravimab+miromavimab contains Docaravimab and miromavimab as its active components. It works by binding to the rabies virus and neutralizing it, providing immediate passive immunity to individuals exposed to the virus.

Docaravimab+miromavimab causes side effects such as injection site reactions like pain, redness, swelling, and low-grade fever. Therefore, contact a doctor if these side effects persist or worsen.

Docaravimab+miromavimab is stored in temperatures between 2°C and 8°C. Protect from light. Do not freeze. Keep out of reach of children.

No, Docaravimab+miromavimab is strictly a preventative treatment meant to be used immediately after exposure. Once clinical symptoms of rabies appear, the infection is almost always fatal, and preventative antibody treatments are no longer effective. Talk to your doctor immediately if you have been exposed.

Yes, because rabies is a fatal disease, the life-saving benefits of receiving Docaravimab+miromavimab far outweigh any theoretical risks during pregnancy. If you are pregnant or breastfeeding, you should still receive this treatment immediately after exposure. Talk to your doctor to discuss any questions.

You should receive Docaravimab+miromavimab as soon as possible after a suspected exposure, ideally within the first 24 to 72 hours. Delaying treatment decreases its effectiveness, so seek emergency medical care immediately. Talk to your doctor if you have concerns about the timing.

Yes, whenever physically possible, the doctor will inject as much of the dose as possible directly into and around your bite or scratch wounds. This helps neutralise the rabies virus right where it entered your body. Talk to your doctor about how your specific wounds will be treated.

If you have completed a full pre-exposure or post-exposure rabies vaccine series in the past, you generally do not need to receive Docaravimab+miromavimab. Your body already has memory cells to fight the virus, and you will only need booster doses of the vaccine. Talk to your doctor to confirm your vaccination history.

Docaravimab+miromavimab provides passive immunity by delivering pre-made antibodies that fight the virus immediately, while the rabies vaccine stimulates your own immune system to make its own antibodies over several weeks. They are used together to give you both immediate and long-term protection. Talk to your doctor for more details.

It is highly recommended to avoid alcohol while receiving treatment for rabies exposure. Alcohol can weaken your immune system and mimic or mask side effects of the treatment, making it harder for doctors to evaluate your recovery. Talk to your doctor for specific advice.

Yes, children can safely receive Docaravimab+miromavimab. The dosage is carefully calculated based on the child's body weight to ensure safe and effective protection against the rabies virus. Talk to your doctor if you have any questions about your child's treatment plan.

Apollo 247 Floating Button